AB₅ Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins

Area of Science:

• Foodborne pathogens
• Bacterial toxins
• Molecular mechanisms of infection

Background:

• Foodborne diseases impact 600 million globally, often caused by bacteria like E. coli.
• AB5 toxins, including Shiga toxins (Stx), are key virulence factors causing severe symptoms like hemolytic uremic syndrome (HUS).
• Antibiotic use for STEC infections is debated due to HUS risk, necessitating alternative strategies.

Purpose of the Study:

• To review the mechanisms of action and pathogenesis of AB5 toxins from foodborne pathogens, focusing on Shiga toxins (Stx).
• To discuss the role of Stx in human STEC disease, detection, and current treatment limitations.
• To highlight the public health threat of STEC and the need for exploring antibiotic alternatives.

Main Methods:

• Literature review of scientific articles on bacterial foodborne pathogens, AB5 toxins, and Shiga toxins.
• Analysis of mechanisms of action, pathogenesis, and clinical manifestations related to Stx.
• Synthesis of information on detection methods and treatment strategies for STEC infections.

Main Results:

• Bacterial pathogens utilize virulence factors and toxins, such as AB5 toxins, to cause disease.
• Shiga toxins (Stx) play a critical role in the pathogenesis of STEC infections, leading to HUS.
• Current treatment for STEC infections is limited, with ongoing debate regarding antibiotic efficacy and safety.

Conclusions:

• Understanding Stx mechanisms is crucial for developing effective interventions against STEC.
• Further research into antibiotic alternatives is essential to address the public health challenge posed by STEC outbreaks.
• Improved detection and treatment strategies are needed to combat the global burden of foodborne illnesses caused by bacterial toxins.